TIRUMALCHM2023-04-012023-06-30 TIRUMALCHM2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member TIRUMALCHM2023-04-012023-06-30in-bse-fin:OneOperatingExpenses02Member TIRUMALCHM2023-06-30 TIRUMALCHM2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member TIRUMALCHM2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member TIRUMALCHM2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss03Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 500412 TIRUMALCHM NA Thirumalai Chemicals Limited Equity 2023-04-01 2024-03-31 2023-07-22 2023-07-11 INR Lakhs First quarter 10:30:00 12:50:00 2023-07-22 2023-07-22 Not applicable Single segment Chemical products and its intermediaries 2023-04-01 2023-06-30 Unaudited Standalone 4683400000.00 75200000.00 4758600000.00 3592600000.00 14700000.00 -242000000.00 146400000.00 129000000.00 85800000.00 760500000.00 4487000000.00 271600000.00 0.00 271600000.00 67500000.00 1300000.00 68800000.00 0.00 202800000.00 0.00 0.00 0.00 0.00 202800000.00 23000000.00 225800000.00 0.00 0.00 102400000.00 1 1.98 1.98 0.00 0.00 1.98 1.98 1. The Audit Committee has reviewed and the Board of Directors have approved the above results at their respective meetings held on 21 July 2023 and 22 July 2023. 2. In accordance with Ind AS 108, Operating Segments , the Group has identified manufacture and sale of organic chemicals as the only reportable segment. 3. The Standalone and Consolidated Financial Results have been prepared in accordance with recognition and measurement principles laid down in the Indian Accounting Standard 34, Interim financial reporting (Ind As 34), prescribed under section 133 of the Companies Act 2013, the Act, and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of the Regulation 33 of the SEBI(listing obligation and disclosure requirements) regulations, 2015 as amended. 4. With respect to standalone and consolidated financial results, the figures for the quarter ended 31 March 2023 represent the difference between the audited figures in respect of full financial year ended 31 March 2023 and the unaudited figures for the nine months ended 31 December 2022. 5. Post June 2023, the Holding Company converted a USD 2 million loan provided to its wholly owned subsidiary, Cheminvest Pte. Ltd, into equity. 6. The figures for the corresponding previous periods have been regrouped / reclassified wherever considered necessary to confirm to the figures presented in the current period. Material and Contract Costs 214800000.00 Other expenses 545700000.00 - Re-measurements of defined benefit plans 500000.00 - Equity instruments through other comprehensive income, net 25300000.00 - Income tax relating to items that will not be reclassified to profit and loss -2800000.00 23000000.00 0.00 0.00